Compare Stocks

Date Range: 

 Moderna
SymbolNASDAQ:MRNA
Price Information
Current Price$158.55
52 Week RangeHold
MarketRank™
Overall Score1.6
Analysis Score2.2
Community Score2.9
Dividend Score0.0
Ownership Score0.8
Earnings & Valuation Score1.9
Analyst Ratings
Consensus RecommendationHold
Consensus Price Target$156.88
% Upside from Price Target-1.05% downside
Trade Information
Market Cap$63.50 billion
Beta1.73
Average Volume11,998,043
Sales & Book Value
Annual Revenue$60.21 million
Price / Sales1,054.70
CashflowN/A
Price / CashN/A
Book Value$3.49 per share
Price / Book45.43
Profitability
Net Income$-514,020,000.00
EPS($1.55)
Trailing P/E RatioN/A
Forward P/E Ratio15.17
P/E Growth0.53
Net Margins-242.73%
Return on Equity (ROE)-28.11%
Return on Assets (ROA)-20.31%
Dividend
Annual PayoutN/A
Dividend YieldN/A
Three-Year Dividend GrowthN/A
Payout RatioN/A
Years of Consecutive Dividend GrowthN/A
Debt
Debt-to-Equity Ratio0.04%
Current Ratio2.43%
Quick Ratio2.43%
Ownership Information
Institutional Ownership Percentage51.21%
Insider Ownership Percentage29.20%
Miscellaneous
Employees1,300
Shares Outstanding400.53 million
Next Earnings Date8/4/2021 (Estimated)
OptionableOptionable
SourceHeadline
UK named as selection for Moderna study - Kentucky TodayUK named as selection for Moderna study - Kentucky Today
kentuckytoday.com - May 11 at 12:29 AM
Emory partnering in Moderna COVID-19 vaccine study for children - Atlanta Journal ConstitutionEmory partnering in Moderna COVID-19 vaccine study for children - Atlanta Journal Constitution
ajc.com - May 10 at 7:28 PM
Moderna vaccine trial data shows promising results in children - Live 5 News WCSCModerna vaccine trial data shows promising results in children - Live 5 News WCSC
live5news.com - May 10 at 7:28 PM
The U.S. will begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer’s vaccine gets expanded authorizationThe U.S. will begin giving COVID-19 shots to 12- to 15-year-olds as Pfizer’s vaccine gets expanded authorization
finance.yahoo.com - May 10 at 7:28 PM
Were Hedge Funds Right About Piling Into Moderna (MRNA)?Were Hedge Funds Right About Piling Into Moderna (MRNA)?
finance.yahoo.com - May 10 at 7:28 PM
PM360 Names Stéphane Bancel, CEO of Moderna, the 2021 Uber ELITE Winner - Salamanca PressPM360 Names Stéphane Bancel, CEO of Moderna, the 2021 Uber ELITE Winner - Salamanca Press
salamancapress.com - May 10 at 2:28 PM
University of Kentucky to host Moderna COVID-19 vaccine study - WSAZ-TVUniversity of Kentucky to host Moderna COVID-19 vaccine study - WSAZ-TV
wsaz.com - May 10 at 2:28 PM
Moderna COVID-19 Vaccine Event May 16 - The ChattanooganModerna COVID-19 Vaccine Event May 16 - The Chattanoogan
chattanoogan.com - May 10 at 2:28 PM
Moderna says booster shot effective against variants; undetected early heart damage raises risk of death for - cleveland.comModerna says booster shot effective against variants; undetected early heart damage raises risk of death for - cleveland.com
cleveland.com - May 10 at 2:28 PM
Pfizer, Moderna or J&J? An Expert Answers Your Questions - U.S. News & World ReportPfizer, Moderna or J&J? An Expert Answers Your Questions - U.S. News & World Report
usnews.com - May 10 at 2:28 PM
The company behind Moderna has a new RNA startup looking to disrupt drugmaking. The goal? 100 new drugs in 10 years - Endpoints NewsThe company behind Moderna has a new RNA startup looking to disrupt drugmaking. The goal? 100 new drugs in 10 years - Endpoints News
endpts.com - May 10 at 9:27 AM
Latest vaccine clinic at IMS will administer J&J, Moderna, Pfizer shots at some point throughout run - Fox 59Latest vaccine clinic at IMS will administer J&J, Moderna, Pfizer shots at some point throughout run - Fox 59
fox59.com - May 10 at 9:27 AM
Moderna founder launches new biotech, looking to cure diseases through endless RNA - BioPharma DiveModerna founder launches new biotech, looking to cure diseases through 'endless RNA' - BioPharma Dive
biopharmadive.com - May 10 at 9:27 AM
Modernas Vaccine Produces Antibodies for at Least 6 Months - Motley FoolModerna's Vaccine Produces Antibodies for at Least 6 Months - Motley Fool
fool.com - May 10 at 9:27 AM
UPDATE 1-GAVI in talks with Chinas Sinopharm, other vaccine makers for COVAX dosesUPDATE 1-GAVI in talks with China's Sinopharm, other vaccine makers for COVAX doses
finance.yahoo.com - May 10 at 9:27 AM
Modernas Vaccine Produces Antibodies for at Least 6 MonthsModerna's Vaccine Produces Antibodies for at Least 6 Months
finance.yahoo.com - May 10 at 9:27 AM
Fingerlakes Mall to host first dose of the Moderna covid-19 vaccine clinic tomorrow - CNYcentral.comFingerlakes Mall to host first dose of the Moderna covid-19 vaccine clinic tomorrow - CNYcentral.com
cnycentral.com - May 10 at 4:27 AM
Fingerlakes Mall to host first dose of the Moderna covid-19 vaccine clinic tomorrow - CNYcentral.comFingerlakes Mall to host first dose of the Moderna covid-19 vaccine clinic tomorrow - CNYcentral.com
cnycentral.com - May 10 at 4:27 AM
Takeda reports positive interim results of Moderna trials in Japan - NasdaqTakeda reports positive interim results of Moderna trials in Japan - Nasdaq
nasdaq.com - May 10 at 4:27 AM
Takeda reports positive interim results of Moderna trials in Japan - NasdaqTakeda reports positive interim results of Moderna trials in Japan - Nasdaq
nasdaq.com - May 10 at 4:27 AM
Q2 2021 Earnings Estimate for Moderna, Inc. (NASDAQ:MRNA) Issued By SVB LeerinkQ2 2021 Earnings Estimate for Moderna, Inc. (NASDAQ:MRNA) Issued By SVB Leerink
americanbankingnews.com - May 10 at 2:18 AM
First of three South Korea expert panels recommends approval of Moderna COVID-19 vaccine - KFGO NewsFirst of three South Korea expert panels recommends approval of Moderna COVID-19 vaccine - KFGO News
kfgo.com - May 9 at 10:21 PM
First of three S.Korea expert panels recommends approval of Moderna COVID-19 vaccineFirst of three S.Korea expert panels recommends approval of Moderna COVID-19 vaccine
finance.yahoo.com - May 9 at 10:21 PM
Phoenix-Talent School District hosts Moderna vaccine clinic - KDRVPhoenix-Talent School District hosts Moderna vaccine clinic - KDRV
kdrv.com - May 9 at 12:20 PM
Johns Island clinic offers Moderna vaccine - Live 5 News WCSCJohns Island clinic offers Moderna vaccine - Live 5 News WCSC
live5news.com - May 9 at 12:20 PM
Moderna (NASDAQ:MRNA) Upgraded at TheStreetModerna (NASDAQ:MRNA) Upgraded at TheStreet
marketbeat.com - May 8 at 7:07 AM
Correction: Virus Outbreak-WHO-Moderna Vaccine storyCorrection: Virus Outbreak-WHO-Moderna Vaccine story
marketbeat.com - May 4 at 7:44 AM
UN program inks Moderna deal on 500M doses, starting in Q4 UN program inks Moderna deal on 500M doses, starting in Q4
marketbeat.com - May 3 at 6:59 AM
The Latest: Moderna beefs up manufacturing for 2021-22 dosesThe Latest: Moderna beefs up manufacturing for 2021-22 doses
marketbeat.com - April 29 at 1:32 AM
Moderna (NASDAQ:MRNA) Stock Rating Reaffirmed by Piper SandlerModerna (NASDAQ:MRNA) Stock Rating Reaffirmed by Piper Sandler
marketbeat.com - April 21 at 8:50 AM
Are These Covid Treatment Makers Getting A Price Booster Shot? (MRNA)Are These Covid Treatment Makers Getting A Price Booster Shot? (MRNA)
marketbeat.com - April 20 at 4:59 PM
3 Bullish Chart Patterns with Good Fundamentals3 Bullish Chart Patterns with Good Fundamentals
marketbeat.com - April 12 at 1:18 PM
The Moderna Pullback is Worth a ShotThe Moderna Pullback is Worth a Shot
marketbeat.com - April 6 at 1:06 PM
Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better (MRNA)Buy Johnson & Johnson (NYSE:JNJ) Before Good News Gets Even Better (MRNA)
marketbeat.com - January 26 at 12:15 PM
Time to Sell the News on Moderna (NASDAQ: MRNA) Stock Time to Sell the News on Moderna (NASDAQ: MRNA) Stock
marketbeat.com - December 28 at 9:22 AM
Jefferies Downgrades Moderna (NASDAQ:MRNA), Suggests Success Already Priced In (MRNA)Jefferies Downgrades Moderna (NASDAQ:MRNA), Suggests Success Already Priced In (MRNA)
marketbeat.com - December 16 at 11:43 AM
Wells Fargo (NYSE: WFC) Lining Up For A Killer December and Q1 (MRNA)Wells Fargo (NYSE: WFC) Lining Up For A Killer December and Q1 (MRNA)
marketbeat.com - December 1 at 8:57 AM
Moderna (NASDAQ:MRNA) Makes Explosive Gains in Pre-Market (MRNA)Moderna (NASDAQ:MRNA) Makes Explosive Gains in Pre-Market (MRNA)
marketbeat.com - November 30 at 11:15 AM
How to Invest After a Turbulent 2020 Election (MRNA)How to Invest After a Turbulent 2020 Election (MRNA)
marketbeat.com - November 23 at 5:51 PM
COVID-19 Vaccine Results See AstraZeneca (LON:AZN) Slip a Bit (MRNA)COVID-19 Vaccine Results See AstraZeneca (LON:AZN) Slip a Bit (MRNA)
marketbeat.com - November 19 at 12:08 PM
The Cheesecake Factory Continues to Look Appetizing (NASDAQ: CAKE) (MRNA)The Cheesecake Factory Continues to Look Appetizing (NASDAQ: CAKE) (MRNA)
marketbeat.com - November 17 at 9:26 AM
Moderna (NASDAQ:MRNA) Makes Moves on Drug GainsModerna (NASDAQ:MRNA) Makes Moves on Drug Gains
marketbeat.com - November 12 at 11:41 AM
DateCompanyBrokerageAction
5/7/2021ModernaChardan CapitalBoost Price Target
5/7/2021ModernaMorgan StanleyLower Price Target
5/7/2021ModernaBarclaysBoost Price Target
5/7/2021ModernaThe Goldman Sachs GroupBoost Price Target
5/6/2021ModernaPiper SandlerLower Price Target
5/5/2021ModernaJefferies Financial GroupReiterated Rating
4/18/2021ModernaSVB LeerinkReiterated Rating
4/16/2021ModernaNeedham & Company LLCReiterated Rating
3/4/2021ModernaBrookline Capital ManagementBoost Price Target
2/26/2021ModernaBank of AmericaReiterated Rating
2/1/2021ModernaOppenheimerBoost Price Target
(Data available from 5/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.